1. Home
  2. AVBP vs AVAH Comparison

AVBP vs AVAH Comparison

Compare AVBP & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • AVAH
  • Stock Information
  • Founded
  • AVBP 2021
  • AVAH 1984
  • Country
  • AVBP United States
  • AVAH United States
  • Employees
  • AVBP N/A
  • AVAH N/A
  • Industry
  • AVBP
  • AVAH Hospital/Nursing Management
  • Sector
  • AVBP
  • AVAH Health Care
  • Exchange
  • AVBP NYSE
  • AVAH Nasdaq
  • Market Cap
  • AVBP 879.2M
  • AVAH 736.2M
  • IPO Year
  • AVBP 2024
  • AVAH 2021
  • Fundamental
  • Price
  • AVBP $21.75
  • AVAH $5.14
  • Analyst Decision
  • AVBP Strong Buy
  • AVAH Hold
  • Analyst Count
  • AVBP 5
  • AVAH 4
  • Target Price
  • AVBP $39.40
  • AVAH $4.51
  • AVG Volume (30 Days)
  • AVBP 172.1K
  • AVAH 347.2K
  • Earning Date
  • AVBP 03-03-2025
  • AVAH 03-13-2025
  • Dividend Yield
  • AVBP N/A
  • AVAH N/A
  • EPS Growth
  • AVBP N/A
  • AVAH N/A
  • EPS
  • AVBP N/A
  • AVAH N/A
  • Revenue
  • AVBP N/A
  • AVAH $2,024,506,000.00
  • Revenue This Year
  • AVBP N/A
  • AVAH $7.85
  • Revenue Next Year
  • AVBP N/A
  • AVAH $5.09
  • P/E Ratio
  • AVBP N/A
  • AVAH N/A
  • Revenue Growth
  • AVBP N/A
  • AVAH 6.82
  • 52 Week Low
  • AVBP $14.35
  • AVAH $2.11
  • 52 Week High
  • AVBP $36.37
  • AVAH $6.19
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 32.12
  • AVAH 63.63
  • Support Level
  • AVBP $21.34
  • AVAH $3.68
  • Resistance Level
  • AVBP $22.75
  • AVAH $3.92
  • Average True Range (ATR)
  • AVBP 1.40
  • AVAH 0.28
  • MACD
  • AVBP -0.14
  • AVAH 0.05
  • Stochastic Oscillator
  • AVBP 8.41
  • AVAH 87.50

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About AVAH Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is primarily derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.

Share on Social Networks: